查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014547

跳蚤和蜱蟲防治產品市場：按產品類型、目標動物和銷售管道分類的全球市場預測，2026-2032年

Flea & Tick Product Market by Product Type, Animal Type, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，跳蚤和蜱蟲防治產品市場價值將達到 18.9 億美元，到 2026 年將成長到 20.2 億美元，到 2032 年將達到 30.2 億美元，複合年成長率為 6.93%。

主要市場統計數據
基準年 2025 18.9億美元
預計年份：2026年 20.2億美元
預測年份 2032 30.2億美元
複合年成長率 (%) 6.93%

本文全面概述了寵物飼養模式的變化、監管重點和消費者期望如何重塑該類別的產品和銷售管道重點。

受寵物飼養模式的改變、消費者對安全性和便利性日益成長的期望以及監管力度加大的影響，跳蚤和蜱蟲防治產品的市場格局正進入一個戰略關注度更高的階段。產品開發、分銷和獸醫服務領域的相關人員正在重新評估產品的定位，力求在有效性、易用性和負責任的管理之間取得平衡。隨著寵物與家庭的融合程度越來越高，家庭結構也朝著更「人性化」的方向發展，市場需求的促進因素正在重新定義何為「可接受的」、「優質的」或「必要的」干預措施。

簡要分析推動產品開發和分銷管道創新和新興競爭動態的技術、行為和監管變化。

跳蚤和蜱蟲防治產品領域近期發生的變革性變化，反映了由技術進步、寵物飼主行為變化以及法規結構強化所驅動的競爭優勢的重新定義。藥物科學的進步使得更易偏好的口服藥物和藥效更持久的外用製劑得以研發，從而影響了消費者的偏好和用藥依從性。同時，數位化資訊管道和遠距遠端醫療互動提高了消費者的認知度，使他們成為更明智的消費者，要求產品提供基於實證醫學的療效聲明和透明的安全資訊。

對近期關稅調整如何促進供應鏈多元化、採購韌性和協調定價策略的營運和商業分析。

美國於2025年實施的新關稅措施進一步增加了跳蚤和蜱蟲防治產品生態系統中企業的供應鏈和採購複雜性。關稅調整迫使企業重新評估籌資策略，促使它們更加重視供應商多元化和近岸外包。這種調整影響了前置作業時間、庫存策略和採購成本基準值，需要商業規劃和供應鏈營運之間更緊密的協調。

從詳細的細分觀點解釋產品劑型、動物物種特定考慮因素和銷售管道選擇如何共同塑造產品滲透趨勢和策略權衡。

了解市場區隔動態對於跳蚤和蜱蟲防治產品系列的開發和市場進入策略至關重要。根據產品類型，市場可細分為項圈、口服藥物、洗髮精/浸泡液、滴劑和噴霧劑，其中口服藥物可進一步細分為咀嚼片和片劑。每種劑型都具有獨特的特性，這些特性與飼主的便利性、劑量準確性和安全性密切相關。例如，項圈是一種被動式、使用頻率低的干涉措施，適合希望盡量減少麻煩的飼主。滴劑雖然需要局部塗抹，但通常因其起效迅速和使用方便而受到青睞。口服藥物，無論是咀嚼錠或錠劑，如果偏好和給藥方式得到最佳化，通常有助於提高遵守用藥性。

區域分析解釋了不同的管理體制、消費者行為和分銷基礎設施如何塑造美洲、歐洲、中東、非洲和亞太地區的區域策略。

區域趨勢對全球跳蚤和蜱蟲防治產業的監管環境、消費者偏好和分銷基礎設施有顯著影響。在美洲，消費者需求模式和獸醫分銷網路共同創造了一個專家建議與傳統零售通路並存的環境，這就要求製造商將臨床資訊與零售訊息相協調。在歐洲、中東和非洲，法規結構和文化習俗呈現出多元化的特點，因此，區域安全演示和標籤標準化對於跨境市場准入至關重要。在某些地區，環境管理和殘留物問題尤其需要關注。亞太地區的特點是快速的都市化和多元化的零售現代化，這兩者共同加速了線上銷售的普及，同時也要求企業進行符合當地文化的定位，以適應寵物護理傳統和獸醫實踐。

策略競爭概覽，展示了成熟品牌、敏捷創新者和通路夥伴關係如何定義競爭格局和產品差異化策略。

跳蚤和蜱蟲防治產品市場的競爭格局呈現出多元化的態勢，既有老牌企業，也有利用配方技術進步的參與企業，還有專注於特定給藥系統的專業創新者。老牌企業優先考慮可靠的臨床數據和廣泛的分銷協議，以維護與獸醫專業人士和零售合作夥伴的關係，並持續投資於產品改進和品牌信譽的提升。同時，靈活的製造商和自有品牌開發商正在開發差異化提案，強調更簡單的給藥方法、良好的安全性或更低的成本，以吸引對價格敏感的消費者。

為經營團隊提供切實可行的策略建議，以協調研發、供應鏈韌性和通路主導的商業化，從而確保永續的競爭優勢。

產業領導企業可以採取實際措施，增強韌性，並在產品、價值鏈和商業領域加速價值創造。首先，應優先加強研發、監管和商業團隊之間的跨職能協作，確保產品創新得到數據和展示策略的支持，從而實現快速推廣。這種協作能夠減少產品上市的阻力，並打造出能引起臨床醫師和消費者共鳴的可信賴產品。其次，應實現供應商網路多元化，並探索近岸外包和在地化生產方案，以降低貿易政策波動帶來的風險，並縮短關鍵零件的前置作業時間。

對調查方法進行了清晰嚴謹的描述，解釋瞭如何將一手訪談、第二手資料整合和專家檢驗結合起來，從而得出可靠且可操作的見解。

本分析的調查方法結合了質性訪談、二手文獻整合以及跨領域專家檢驗，旨在得出平衡且切實可行的結論。一手資料包括對製造和分銷機構的產品開發經理、監管專家、供應鏈經理和銷售主管進行的結構化訪談，以獲取有關營運限制因素和戰略重點的第一手觀點。二手資料整合則利用公開的監管公告、臨床試驗摘要和行業評論，為觀察到的行業趨勢和監管動態提供背景資訊。

透過整合產品創新、區域特徵、監管壓力和營運韌性進行分析，為決策者得出連貫的策略結論。

總之，跳蚤和蜱蟲防治產品類型正經歷著策略重組，其驅動力包括劑型創新、消費者行為更加理性以及監管趨勢對更強證據和供應鏈韌性的要求。產品按劑型（項圈、口服藥物、洗髮精/浸液、滴劑、噴霧劑）、物種特異性（貓和狗）以及線上線下配銷通路的不同趨勢進行細分，這些因素都帶來了關鍵的商業挑戰。同時，美洲、歐洲、中東和非洲以及亞太地區的區域差異也要求制定在地化的策略，以尊重監管細則和文化偏好。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 跳蚤和蜱蟲防治產品市場：依產品類型分類

  • 衣領
  • 口服
    • 咀嚼片
    • 藥片
  • 洗髮精浸泡
  • 完全正確
  • 噴

第9章 跳蚤和蜱蟲防治產品市場：依動物類型分類

  • 貓
  • 狗

第10章 跳蚤和蜱蟲防治產品市場：按分銷管道分類

  • 離線
  • 線上

第11章 跳蚤和蜱蟲防治產品市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 跳蚤和蜱蟲防治產品市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 跳蚤和蜱蟲防治產品市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國跳蚤和蜱蟲防治產品市場

第15章：中國跳蚤和蜱蟲防治產品市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advanced PetCare of Northern Nevada, Inc.
  • Beaphar BV
  • Boehringer Ingelheim International GmbH
  • Central Garden & Pet Company
  • Ceva Sante Animale SA
  • Dechra Pharmaceuticals PLC
  • Ecto Development Corporation
  • Elanco Animal Health Incorporated
  • Eli Lilly and Company
  • Godrej Consumer Products Limited
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • Merck & Co., Inc.
  • Merial
  • Norbrook Laboratories Limited
  • PetIQ, Inc.
  • Radio Systems Corporation
  • Sergeant's Pet Care Products, Inc.
  • Sogeval SA
  • Spectrum Brands Holdings, Inc.
  • Sumitomo Chemical Co., Ltd.
  • The Hartz Mountain Corporation
  • Vetoquinol SA
  • Virbac SA
  • Wellmark International, Inc.
  • Zoetis Inc.
Product Code: MRR-4348D129FB5F

The Flea & Tick Product Market was valued at USD 1.89 billion in 2025 and is projected to grow to USD 2.02 billion in 2026, with a CAGR of 6.93%, reaching USD 3.02 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.89 billion
Estimated Year [2026] USD 2.02 billion
Forecast Year [2032] USD 3.02 billion
CAGR (%) 6.93%

An integrative introduction describing how shifting pet ownership patterns, regulatory emphasis, and consumer expectations are reshaping product and channel priorities in the category

The landscape for flea and tick products has entered a phase of heightened strategic attention driven by evolving pet ownership patterns, rising consumer expectations for safety and convenience, and intensifying regulatory scrutiny. Stakeholders across product development, distribution, and veterinary services are reassessing how to position offerings that need to balance efficacy, ease of use, and responsible stewardship. As pets become integrated into more households and family dynamics shift toward humanization, demand drivers are recalibrating what constitutes an acceptable, premium, or essential intervention.

Manufacturers are responding by reformulating delivery mechanisms and emphasizing differentiated claims that align with contemporary pet parent priorities, such as long-lasting protection, palatable oral formats, and topical options that minimize stress during administration. In parallel, retailers and veterinary networks are adapting merchandising and educational strategies to address buyer literacy about product trade-offs and behavioral adherence. These converging trends are fostering an environment where product innovation, clear communication, and robust safety data are core determinants of commercial success.

Transitioning from traditional category playbooks, companies now prioritize integrated go-to-market strategies that combine clinical credibility with consumer-centric convenience. This shift demands a deeper understanding of how product attributes, animal type considerations, and channel experiences intersect to shape purchasing decisions and long-term loyalty.

A concise exploration of the technological, behavioral, and regulatory shifts catalyzing innovation and new competitive dynamics across product development and distribution channels

Recent transformative shifts in the flea and tick product environment reflect a confluence of technological advances, behavioral changes among pet owners, and tightened regulatory frameworks that together redefine competitive advantage. Advances in formulation science have enabled the development of oral options with improved palatability and topical agents with longer residual activity, which in turn influence consumer preference hierarchies and adherence patterns. Concurrently, digital information channels and telehealth interactions have elevated consumer awareness, creating more informed purchasers who demand evidence-based claims and transparent safety profiles.

Moreover, the retail landscape has evolved as omnichannel expectations increase; consumers expect seamless discovery, access to professional guidance, and convenient replenishment regardless of whether they shop through brick-and-mortar clinics, mass-market retailers, or online platforms. This behavioral shift pressures manufacturers to deliver clear, consistent messaging across disparate touchpoints. At the same time, regulatory authorities have intensified oversight on active ingredient approvals, labeling precision, and claims substantiation, prompting firms to invest in stronger clinical and safety data packages.

Taken together, these shifts are pushing industry players to blend scientific rigor with consumer-centric design and multichannel execution, thereby privileging organizations that can pivot quickly while maintaining trust and compliance.

An operational and commercial analysis of how recent tariff adjustments have compelled supply chain diversification, procurement resilience, and collaborative pricing strategies

The introduction of new tariff measures within the United States in 2025 has introduced a layer of supply chain and procurement complexity for companies active in the flea and tick product ecosystem. Tariff adjustments have prompted firms to re-evaluate sourcing strategies for active pharmaceutical ingredients and packaging components, with greater attention on supplier diversification and nearshoring alternatives. This recalibration has implications for lead times, inventory policies, and procurement cost baselines, requiring tighter coordination between commercial planning and supply chain operations.

As a result, manufacturers that had relied on single-source international suppliers have accelerated efforts to qualify secondary suppliers and to secure contingency inventory where feasible. Firms also increased engagement with logistics providers to mitigate shipment delays and to optimize routing that minimizes exposure to incremental duties. In parallel, procurement teams implemented more granular cost-to-serve analyses to understand how tariff-induced cost changes influence pricing flexibility and margin trade-offs.

Importantly, the tariff environment is encouraging strategic dialogues between manufacturers and distribution partners about cost-sharing mechanisms, rebate structures, and promotional commitments to preserve retail price competitiveness. These conversations frequently lead to collaborative scenarios where commercial teams prioritize product bundles, subscription models, or promotional cadence adjustments to sustain volume while absorbing part of the cost impact. In sum, tariff-driven pressures are reshaping operational resilience and commercial negotiations, reinforcing the importance of integrated cross-functional planning.

A nuanced segmentation perspective explaining how product delivery formats, animal-specific considerations, and channel selection converge to shape adoption dynamics and strategic trade-offs

Understanding segmentation dynamics is critical to shaping product portfolios and go-to-market strategies within the flea and tick category. Based on product type, the market is studied across Collar, Oral, Shampoo & Dip, Spot-On, and Spray, with Oral further differentiated into Chewable and Tablet; each delivery format carries distinct attributes related to owner convenience, dosing accuracy, and perceived safety. For instance, collars provide passive, low-frequency intervention suitable for owners seeking minimal handling, whereas spot-on formulations require topical application and are often chosen for perceived immediacy and ease of use. Oral formats, whether chewable or tablet, frequently benefit from adherence advantages when palatability and administration are optimized.

Based on animal type, the market is studied across Cat and Dog, and species-specific physiology, tolerance profiles, and behavioral characteristics influence product suitability and label design. Cats, for example, necessitate formulations with stricter safety margins and careful consideration of grooming behavior, while dogs offer broader formulation options that must account for size and weight variability. Based on distribution channel, the market is studied across Offline and Online, and channel choice strongly shapes purchasing behavior, educational touchpoints, and repeat-buy mechanisms. Offline channels, including veterinary clinics and specialty retailers, often serve as trusted advisors that influence adoption through professional recommendation, whereas online channels expand access and enable subscription-based replenishment models that reward stickiness.

Consequently, segmentation insights inform targeted messaging, packaging decisions, and clinical evidence investments required to win in each product-animal-channel intersection.

A regional analysis describing how divergent regulatory regimes, consumer behaviors, and distribution infrastructures shape tailored strategies in the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics exert a powerful influence on regulatory approaches, consumer preferences, and distribution infrastructures across the global flea and tick landscape. In the Americas, consumer demand patterns and veterinary distribution networks create an environment where professional endorsement and familiar retail channels coexist, prompting manufacturers to align clinical communication with retail-friendly messaging. Europe, Middle East & Africa present a mosaic of regulatory frameworks and cultural practices that necessitate localized safety substantiation and label harmonization to achieve cross-border access, with particular attention to environmental stewardship and residue considerations in certain jurisdictions. Asia-Pacific is characterized by rapid urbanization and diverse retail modernization trajectories, which together accelerate online adoption while also requiring culturally relevant positioning to address pet care traditions and veterinary practice norms.

Across these regions, differences in reimbursement models, veterinary density, and consumer willingness to pay influence how products are marketed and supported. Manufacturers must therefore calibrate their regional strategies to balance centralized global platforms with local market adaptations, ensuring that product claims, packaging language, and educational assets resonate with local stakeholders. Additionally, supply chain configuration and regulatory registration timelines vary by region, reinforcing the need for phased market entry plans that align manufacturing capacity with incremental market access milestones.

In effect, regional insights guide choices around portfolio prioritization, evidence generation, and channel investment to maximize relevance and operational feasibility in distinct geographies.

A strategic competitive overview illustrating how established brands, agile innovators, and channel partnerships are defining the competitive contours and product differentiation strategies

Competitive dynamics within the flea and tick product landscape reflect a blend of legacy brand strength, new entrants leveraging formulation advances, and specialist innovators focused on niche delivery systems. Established companies continue to invest in incremental product improvements and brand trust, emphasizing robust clinical data and broad distribution agreements to maintain relationships with veterinary professionals and retail partners. At the same time, agile manufacturers and private-label players introduce differentiated propositions that emphasize simpler administration, favorable safety profiles, or lower-cost alternatives that appeal to cost-sensitive segments.

Strategically, companies are differentiating along multiple vectors: formulation innovation, consumer convenience, evidence-backed claims, and omnichannel presence. Partnerships and strategic alliances between manufacturers and distribution platforms are increasingly common, enabling faster market access and co-marketing opportunities. In addition, several companies are deploying lifecycle management approaches to extend product relevance through line extensions or repackaging that addresses specific animal type needs or channel preferences.

As competition intensifies, leaders combine rigorous clinical programs with targeted marketing and channel strategies, while emerging players focus on speed-to-market and experimental go-to-market models to capture niche demand. Ultimately, success favors organizations that can integrate scientific credibility with pragmatic commercialization capabilities.

Actionable strategic recommendations for executive teams to align R&D, supply chain resilience, and channel-led commercialization for sustained competitive advantage

Industry leaders can take concrete steps to strengthen resilience and accelerate value capture across product, supply chain, and commercial domains. First, prioritize cross-functional integration between R&D, regulatory, and commercial teams to ensure that product innovations are supported by the data and labeling strategies required for rapid adoption. This alignment reduces time-to-adoption friction and supports credible claims that resonate with both clinicians and consumers. Second, diversify supplier networks and evaluate nearshoring or regional manufacturing options to mitigate exposure to trade policy volatility and to shorten lead times for critical components.

Third, refine channel strategies by tailoring messaging and packaging to the distinctive needs of clinic-based veterinary channels and online retail ecosystems, thereby enhancing conversion and repeat purchase rates. Fourth, invest in post-market surveillance and safety communication systems to build trust and enable rapid response to any adverse events or regulatory inquiries. Fifth, pursue targeted partnerships with telehealth providers, subscription platforms, and retailers to expand access while preserving professional oversight.

Finally, adopt a data-driven commercial approach that links segmentation insights to customer lifetime value metrics, enabling prioritized investment in the product-animal-channel combinations that promise the most durable returns. Together, these actions create an adaptable operating model that balances growth with compliance and customer trust.

A clear and rigorous methodological explanation describing how primary interviews, secondary synthesis, and expert validation were combined to produce robust actionable insights

The research methodology underpinning this analysis combines primary qualitative interviews, secondary literature synthesis, and cross-functional expert validation to ensure balanced, actionable conclusions. Primary inputs include structured interviews with product development leaders, regulatory specialists, supply chain managers, and commercial executives across manufacturer and distributor organizations, capturing firsthand perspectives on operational constraints and strategic priorities. Secondary synthesis draws on publicly available regulatory notices, clinical study summaries, and trade commentary to contextualize observed industry behaviors and regulatory trends.

Data triangulation is achieved by cross-referencing interview insights with documented regulatory changes and observable commercial actions such as distribution agreements and product registrations. The analysis also employs scenario-based stress testing to evaluate how policy shifts and supply chain disruptions could influence operational choices without projecting specific market sizes. Findings were iteratively reviewed by subject matter experts to ensure practical relevance and to validate the plausibility of strategic implications.

Transparency of approach is maintained through explicit documentation of data sources, interviewee roles, and analytical assumptions, enabling clients to understand the provenance of conclusions and to adapt the methodology for customized deep dives where necessary.

A synthesis that ties together product innovation, regional nuances, regulatory pressures, and operational resilience into a coherent strategic conclusion for decision-makers

In conclusion, the flea and tick product category is navigating a period of strategic realignment driven by innovation in delivery formats, more informed consumer behavior, and regulatory dynamics that demand stronger evidence and supply chain resilience. Product segmentation across delivery types such as Collar, Oral, Shampoo & Dip, Spot-On, and Spray, animal-specific considerations for Cat and Dog, and the divergent behaviors of Offline and Online distribution channels collectively shape commercial imperatives. Simultaneously, regional variations across the Americas, Europe, Middle East & Africa, and Asia-Pacific necessitate localized strategies that respect regulatory nuances and cultural preferences.

Organizations that succeed will be those that integrate scientific rigor with consumer-centric design, diversify sourcing to manage policy-driven cost and timing shocks, and deploy channel-specific engagement models that reinforce professional trust while leveraging digital convenience. Collaborative commercial mechanisms with trading partners and investments in post-market safety communication will further differentiate leaders. Ultimately, a balanced approach that aligns product innovation with operational resilience and clear, targeted communication will enable companies to navigate current headwinds and capitalize on evolving opportunities in the category.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Flea & Tick Product Market, by Product Type

  • 8.1. Collar
  • 8.2. Oral
    • 8.2.1. Chewable
    • 8.2.2. Tablet
  • 8.3. Shampoo & Dip
  • 8.4. Spot-On
  • 8.5. Spray

9. Flea & Tick Product Market, by Animal Type

  • 9.1. Cat
  • 9.2. Dog

10. Flea & Tick Product Market, by Distribution Channel

  • 10.1. Offline
  • 10.2. Online

11. Flea & Tick Product Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Flea & Tick Product Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Flea & Tick Product Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Flea & Tick Product Market

15. China Flea & Tick Product Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Advanced PetCare of Northern Nevada, Inc.
  • 16.6. Beaphar B.V.
  • 16.7. Boehringer Ingelheim International GmbH
  • 16.8. Central Garden & Pet Company
  • 16.9. Ceva Sante Animale S.A.
  • 16.10. Dechra Pharmaceuticals PLC
  • 16.11. Ecto Development Corporation
  • 16.12. Elanco Animal Health Incorporated
  • 16.13. Eli Lilly and Company
  • 16.14. Godrej Consumer Products Limited
  • 16.15. Heska Corporation
  • 16.16. IDEXX Laboratories, Inc.
  • 16.17. Merck & Co., Inc.
  • 16.18. Merial
  • 16.19. Norbrook Laboratories Limited
  • 16.20. PetIQ, Inc.
  • 16.21. Radio Systems Corporation
  • 16.22. Sergeant's Pet Care Products, Inc.
  • 16.23. Sogeval S.A.
  • 16.24. Spectrum Brands Holdings, Inc.
  • 16.25. Sumitomo Chemical Co., Ltd.
  • 16.26. The Hartz Mountain Corporation
  • 16.27. Vetoquinol S.A.
  • 16.28. Virbac S.A.
  • 16.29. Wellmark International, Inc.
  • 16.30. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FLEA & TICK PRODUCT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FLEA & TICK PRODUCT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES FLEA & TICK PRODUCT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA FLEA & TICK PRODUCT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY COLLAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY COLLAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY COLLAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY CHEWABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY CHEWABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY CHEWABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SHAMPOO & DIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SHAMPOO & DIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SHAMPOO & DIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SPOT-ON, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SPOT-ON, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SPOT-ON, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY CAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY CAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY CAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY DOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY DOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY DOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. AMERICAS FLEA & TICK PRODUCT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 41. AMERICAS FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 42. AMERICAS FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 43. AMERICAS FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. AMERICAS FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 45. NORTH AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. NORTH AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 47. NORTH AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 48. NORTH AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 49. NORTH AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 50. LATIN AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. LATIN AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. LATIN AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 53. LATIN AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 54. LATIN AMERICA FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. EUROPE FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. MIDDLE EAST FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. MIDDLE EAST FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. MIDDLE EAST FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 68. MIDDLE EAST FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. MIDDLE EAST FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 70. AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 73. AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AFRICA FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. ASEAN FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. ASEAN FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASEAN FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 84. ASEAN FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. ASEAN FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. GCC FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GCC FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. GCC FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 89. GCC FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. GCC FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPEAN UNION FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPEAN UNION FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPEAN UNION FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPEAN UNION FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPEAN UNION FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. BRICS FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. BRICS FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. BRICS FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 99. BRICS FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. BRICS FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. G7 FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. G7 FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. G7 FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 104. G7 FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. G7 FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. NATO FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. NATO FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NATO FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 109. NATO FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NATO FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL FLEA & TICK PRODUCT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. UNITED STATES FLEA & TICK PRODUCT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. UNITED STATES FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. UNITED STATES FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 115. UNITED STATES FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. UNITED STATES FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. CHINA FLEA & TICK PRODUCT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. CHINA FLEA & TICK PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. CHINA FLEA & TICK PRODUCT MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 120. CHINA FLEA & TICK PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. CHINA FLEA & TICK PRODUCT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)